AP2011005692A0 - Substituted bicyclic imidazole derivatives as gamma secretase modulators. - Google Patents

Substituted bicyclic imidazole derivatives as gamma secretase modulators.

Info

Publication number
AP2011005692A0
AP2011005692A0 AP2011005692A AP2011005692A AP2011005692A0 AP 2011005692 A0 AP2011005692 A0 AP 2011005692A0 AP 2011005692 A AP2011005692 A AP 2011005692A AP 2011005692 A AP2011005692 A AP 2011005692A AP 2011005692 A0 AP2011005692 A0 AP 2011005692A0
Authority
AP
ARIPO
Prior art keywords
imidazole derivatives
gamma secretase
substituted bicyclic
secretase modulators
bicyclic imidazole
Prior art date
Application number
AP2011005692A
Other languages
English (en)
Inventor
Sven Franciscus Anna Van Brandt
Gregory James Macdonald
Gary John Tresadern
Original Assignee
Orhto Mcneil Janssen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orhto Mcneil Janssen Pharmaceuticals Inc filed Critical Orhto Mcneil Janssen Pharmaceuticals Inc
Publication of AP2011005692A0 publication Critical patent/AP2011005692A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AP2011005692A 2008-12-18 2009-12-16 Substituted bicyclic imidazole derivatives as gamma secretase modulators. AP2011005692A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08172202 2008-12-18
PCT/EP2009/067321 WO2010070008A1 (fr) 2008-12-18 2009-12-16 Dérivés bicycliques substitués d'imidazole comme modulateurs de la gamma-sécrétase

Publications (1)

Publication Number Publication Date
AP2011005692A0 true AP2011005692A0 (en) 2011-06-30

Family

ID=40451180

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2011005692A AP2011005692A0 (en) 2008-12-18 2009-12-16 Substituted bicyclic imidazole derivatives as gamma secretase modulators.

Country Status (21)

Country Link
US (1) US8546440B2 (fr)
EP (1) EP2379552B1 (fr)
JP (2) JP2012512831A (fr)
KR (1) KR20110102455A (fr)
CN (1) CN102256974B (fr)
AP (1) AP2011005692A0 (fr)
AR (1) AR074771A1 (fr)
AU (1) AU2009327103B2 (fr)
BR (1) BRPI0922664A2 (fr)
CA (1) CA2742914A1 (fr)
EA (1) EA018625B1 (fr)
ES (1) ES2460642T3 (fr)
IL (1) IL213563A (fr)
MX (1) MX2011006543A (fr)
NZ (1) NZ594036A (fr)
PA (1) PA8854101A1 (fr)
SG (1) SG172213A1 (fr)
TW (1) TWI438203B (fr)
UA (1) UA104151C2 (fr)
WO (1) WO2010070008A1 (fr)
ZA (1) ZA201104504B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7868001B2 (en) * 2007-11-02 2011-01-11 Hutchison Medipharma Enterprises Limited Cytokine inhibitors
CA2742897A1 (fr) 2008-11-06 2010-05-14 Astrazeneca Ab Modulateurs de la proteine ?-amyloide
PA8854101A1 (es) 2008-12-18 2010-07-27 Ortho Mcneil Janssen Pharm Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
KR20110113197A (ko) 2009-02-06 2011-10-14 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 감마 세크레타제 조절제로서의 신규 치환된 비사이클릭 헤테로사이클릭 화합물
TWI461425B (zh) 2009-02-19 2014-11-21 Janssen Pharmaceuticals Inc 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
EP2427453B1 (fr) 2009-05-07 2013-07-17 Janssen Pharmaceuticals, Inc. Dérivés d'indazole et d'aza-indazole substitués en tant que modulateurs de la gamma secrétase
TWI598347B (zh) 2009-07-13 2017-09-11 基利科學股份有限公司 調節細胞凋亡信號之激酶的抑制劑
CN102482227A (zh) 2009-07-15 2012-05-30 杨森制药公司 作为γ分泌酶调节剂的取代的三唑和咪唑衍生物
BR112012017442A2 (pt) 2010-01-15 2016-04-19 Janssen Pharmaceuticals Inc derivados de triazol bicíclicos substituídos como moduladores de gamma secretase
ES2539257T3 (es) 2010-07-28 2015-06-29 Bayer Intellectual Property Gmbh Imidazo[1,2-b]piridazinas sustituidas
AU2012230348A1 (en) 2011-03-24 2013-08-29 Cellzome Limited Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators
CA2830027C (fr) 2011-03-31 2016-04-26 Pfizer Inc. Nouvelles pyridones bicycliques
US20140255392A1 (en) 2011-04-06 2014-09-11 Bayer Intellectual Property Gmbh Substituted imidazopyridines and intermediates thereof
EP2694510B1 (fr) 2011-04-07 2015-10-14 Bayer Intellectual Property GmbH Imidazopyridazines en tant qu'inhibiteurs de la kinase akt
CN103874702B (zh) 2011-07-15 2015-12-09 杨森制药公司 作为γ分泌酶调节剂的经取代的吲哚衍生物
AU2012325909B2 (en) 2011-10-20 2016-06-09 Glaxosmithkline Llc Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
KR20140077965A (ko) 2011-10-20 2014-06-24 글락소스미스클라인 엘엘씨 시르투인 조절제로서의 치환된 비시클릭 아자-헤테로사이클 및 유사체
WO2013064445A1 (fr) * 2011-11-01 2013-05-10 F. Hoffmann-La Roche Ag Composés d'imidazopyridazine
KR20140108594A (ko) 2012-01-10 2014-09-11 에프. 호프만-라 로슈 아게 피리다진 아미드 화합물 및 syk 저해제로서의 이의 용도
BR112014028395B1 (pt) * 2012-05-16 2022-02-01 Janssen Pharmaceuticals, Inc. Derivados 3,4-di-hidro-2h-pirido[1,2-a]pirazina-1,6-diona substituídos úteis para o tratamento de (inter alia) doença de alzheimer e composição farmacêutica que os compreende
FR2993564B1 (fr) 2012-07-20 2014-08-22 Metabrain Res Derives d'imidazopyridine utiles dans le traitement du diabete
UA110688C2 (uk) 2012-09-21 2016-01-25 Пфайзер Інк. Біциклічні піридинони
AU2013366668B2 (en) 2012-12-20 2017-07-20 Janssen Pharmaceutica Nv Novel tricyclic 3,4-dihydro-2H-pyrido[1,2-alpha]pyrazine -1,6-dione derivatives as gamma secretase modulators
KR102171710B1 (ko) 2013-01-17 2020-10-30 얀센 파마슈티카 엔.브이. 감마 세크레타제 조절 인자로서의 신규 치환 피리도-피페라지논 유도체
ES2697684T3 (es) * 2013-06-12 2019-01-25 Janssen Pharmaceutica Nv Derivados de 4-amino-6-fenil-5,6-dihidroimidazo[1,5 a]pirazina como inhibidores de beta-secretasa (BACE)
US9834559B2 (en) * 2013-06-12 2017-12-05 Janssen Pharmaceutica Nv 4-Amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazin-3(2H)-one derivatives as inhibitors of beta-secretase (BACE)
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
US9856263B2 (en) 2014-04-28 2018-01-02 Pfizer Inc. Heteroaromatic compounds and their use as dopamine D1 ligands
CN107108582B (zh) 2014-12-18 2019-10-18 詹森药业有限公司 β-分泌酶的2，3，4，5-四氢吡啶-6-胺化合物抑制剂
PT3237404T (pt) 2014-12-23 2021-01-19 Gilead Sciences Inc Processos de preparação de inibidores ask1
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
CN107406445B (zh) 2015-02-03 2019-12-24 辉瑞公司 新颖环丙苯并呋喃基吡啶并吡嗪二酮类
BR112017019326B1 (pt) * 2015-03-12 2022-04-26 Fmc Corporation Composto, composição e método para controlar uma praga invertebrada
CA3112349A1 (fr) 2018-10-05 2020-04-09 E. I. Du Pont De Nemours And Company Processus et intermediaires pour la preparation de certains sulfonamides nematicides

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001257022B2 (en) 2000-04-13 2005-02-03 Mayo Foundation For Medical Education And Research Abeta 42 lowering agents
DE10238002A1 (de) 2002-08-20 2004-03-04 Merck Patent Gmbh Benzimidazolderivate
BRPI0410348A (pt) 2003-05-14 2006-05-30 Torreypines Therapeutics Inc compostos e usos dos mesmos na modulação de amilóide-beta
ATE483708T1 (de) 2004-03-08 2010-10-15 Prosidion Ltd Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
EP1757591A4 (fr) 2004-05-26 2010-05-05 Eisai R&D Man Co Ltd Composé de cinnamide
JPWO2006046575A1 (ja) * 2004-10-26 2008-05-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 シンナミド化合物の非晶質体
US7572807B2 (en) 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
US20070078136A1 (en) * 2005-09-22 2007-04-05 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
WO2007043786A1 (fr) * 2005-10-10 2007-04-19 Seiyang Yang Appareil de verification a base dynamique permettant une verification a partir d'un niveau de systeme electronique au niveau grille, et procede de verification utilisant cet appareil
EA200801063A1 (ru) 2005-10-11 2008-12-30 Кемтура Корпорейшн Диароматические амины
US20090163482A1 (en) 2006-03-13 2009-06-25 Mchardy Stanton Furst Tetralines antagonists of the h-3 receptor
GB0606774D0 (en) 2006-04-03 2006-05-10 Novartis Ag Organic compounds
US7893058B2 (en) * 2006-05-15 2011-02-22 Janssen Pharmaceutica Nv Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
WO2008065199A1 (fr) * 2006-12-01 2008-06-05 Galapagos N.V. Composés d'imidazolopyridine pour le traitement des maladies dégénératives et inflammatoires
WO2008082490A2 (fr) * 2006-12-20 2008-07-10 Schering Corporation Nouveaux inhibiteurs de jnk
AU2008214372A1 (en) 2007-02-08 2008-08-14 Merck Sharp & Dohme Corp. Therapeutic agents
JP5209043B2 (ja) 2007-05-07 2013-06-12 メルク・シャープ・アンド・ドーム・コーポレーション ガンマセクレターゼ調節剤
BRPI0811993A2 (pt) * 2007-05-11 2014-11-18 Hoffmann La Roche " hetarilanilinas como moduladores para beta-amiloide ".
WO2008156580A1 (fr) 2007-06-13 2008-12-24 Merck & Co., Inc. Dérivés du triazole destinés au traitement de la maladie d'alzheimer et d'états associés
JP2010532354A (ja) 2007-06-29 2010-10-07 シェーリング コーポレイション γセクレターゼモジュレーター
US7935815B2 (en) * 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
CA2698341A1 (fr) 2007-09-06 2009-03-12 Schering Corporation Modulateurs de la gamma secretase
CN101903775A (zh) 2007-10-19 2010-12-01 Erac股份有限公司 抗edta的s100a12c复合物(erac)
JP2011506335A (ja) 2007-12-06 2011-03-03 シェーリング コーポレイション γ−セクレターゼ調節剤
CA2708300A1 (fr) 2007-12-11 2009-06-18 Schering Corporation Modulateurs de gamma secretase
CN101952275B (zh) 2008-02-22 2014-06-18 弗·哈夫曼-拉罗切有限公司 β-淀粉样蛋白的调节剂
WO2010010188A1 (fr) 2008-07-25 2010-01-28 Galapagos Nv Nouveaux composés utiles pour le traitement de maladies dégénératives et inflammatoires
EP2356115A1 (fr) * 2008-11-06 2011-08-17 Schering Corporation Modulateurs de sécrétase gamma
WO2010065310A1 (fr) 2008-12-03 2010-06-10 Via Pharmaceuticals, Inc Inhibiteurs de l'enzyme diacylglycérol acyltransférase
PA8854101A1 (es) 2008-12-18 2010-07-27 Ortho Mcneil Janssen Pharm Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
KR20110113197A (ko) 2009-02-06 2011-10-14 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 감마 세크레타제 조절제로서의 신규 치환된 비사이클릭 헤테로사이클릭 화합물
TWI461425B (zh) 2009-02-19 2014-11-21 Janssen Pharmaceuticals Inc 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
MX2011011396A (es) 2009-04-27 2012-01-30 High Point Pharmaceuticals Llc DERIVADOS DE IMIDAZO[1,2-A]PIRIDINA SUSTITUIDA, COMPOSICIONES FARMACEUTICAS Y METODOS DE USO COMO INHIBIDORES DE LA ß-SECRETASA.
EP2427453B1 (fr) 2009-05-07 2013-07-17 Janssen Pharmaceuticals, Inc. Dérivés d'indazole et d'aza-indazole substitués en tant que modulateurs de la gamma secrétase
JP2010274429A (ja) 2009-05-26 2010-12-09 Ihi Corp アライメントステージ
CN102482227A (zh) 2009-07-15 2012-05-30 杨森制药公司 作为γ分泌酶调节剂的取代的三唑和咪唑衍生物

Also Published As

Publication number Publication date
AU2009327103B2 (en) 2014-12-04
ES2460642T3 (es) 2014-05-14
NZ594036A (en) 2012-10-26
IL213563A0 (en) 2011-07-31
TW201035093A (en) 2010-10-01
AR074771A1 (es) 2011-02-09
EP2379552A1 (fr) 2011-10-26
EP2379552B1 (fr) 2014-02-26
JP2012512831A (ja) 2012-06-07
UA104151C2 (ru) 2014-01-10
CN102256974B (zh) 2014-07-30
EA201170829A1 (ru) 2011-12-30
US8546440B2 (en) 2013-10-01
PA8854101A1 (es) 2010-07-27
MX2011006543A (es) 2011-07-20
AU2009327103A1 (en) 2011-07-21
TWI438203B (zh) 2014-05-21
KR20110102455A (ko) 2011-09-16
SG172213A1 (en) 2011-07-28
CA2742914A1 (fr) 2010-06-24
BRPI0922664A2 (pt) 2016-01-05
IL213563A (en) 2015-06-30
EA018625B1 (ru) 2013-09-30
US20110237580A1 (en) 2011-09-29
WO2010070008A1 (fr) 2010-06-24
ZA201104504B (en) 2014-01-29
CN102256974A (zh) 2011-11-23
JP2015164969A (ja) 2015-09-17

Similar Documents

Publication Publication Date Title
AP2011005692A0 (en) Substituted bicyclic imidazole derivatives as gamma secretase modulators.
AP2011006034A0 (en) Substituted triazole and imidazole derivatives as gamma secretase modulators.
ZA201205245B (en) Novel substituted bicyclic triazole derivatives as gamma secretase modulators
AP2011005779A0 (en) Novel susbstituted bicyclic heterocyclic compoundsas gamma secretase modulators.
IL212497A0 (en) Heterocyclic gamma secretase modulators
IL206172A0 (en) Gamma secretase modulators
IL201960A0 (en) Gamma secretase modulators
IL209025A0 (en) Urea compounds as gamma secretase modulators
IL230422B (en) Substituted indole derivatives as gamma secretase modulators
HK1163676A1 (en) Bicyclic heterocyclic compound
AU2012285931A1 (en) Novel substituted indole derivatives as gamma secretase modulators
ME02455B (fr) Dérivés d'indazoles à substitutions phényle et benzodioxinyle
ZA200906307B (en) 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators
IL202315A0 (en) Gamma secretase modulators
ZA201108117B (en) Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
ZA201003125B (en) Imidazole derivatives
HRP20130374T1 (en) Pyrrolidin-2-one derivatives as androgen receptor modulators
HK1158198A1 (en) Novel substituted sulfamide derivatives
IL210172A0 (en) Substituted pyrimidin-4-one derivatives
AP2011005725A0 (en) Lactams as beta secretase inhibitors.
IL205148A0 (en) Novel imidazole derivatives
SI2491045T1 (sl) 2-okso-1-pirolidinil imidazotiadiazolni derivati
EP2298767A4 (fr) Composé hétérocyclique bicyclique azoté
IL202316A0 (en) Gamma secretase modulators
IL205149A0 (en) Novel imidazole derivatives